RISE MITCHELL: Open Payments
NPI 1639503816 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$137 in 9 payments from 6 companies in 2025. Trend: 2023 $1,278 · 2024 $2,026 · 2025 $137
Food & beverage: $137
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $48 |
| Axsome Therapeutics, Inc. | 2 | $29 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| Noven Therapeutics, LLC | 1 | $15 |
| Corium, LLC | 1 | $5 |
Products named: CAPLYTA, Auvelity, Jornay PM, SPRAVATO, Xelstrym, Azstarys.
Industry payments across NE — which companies pay providers there.
